Abstract |
The alpha-melanocyte stimulating hormone ( alpha-MSH) analogue [Nle4,D-Phe7]- alpha-MSH was labeled with 18F using N-succinimidyl 4-[18F]fluorobenzoate ([ 18F]SFB) in > 80% radiochemical yield. The IC50 values of [Nle4,D-Phe7]- alpha-MSH and para-fluorobenzoyl-[Nle4, D-Phe7]- alpha-MSH ([Nle4,D-Phe7, Lys 11 -(18F)PFB]- alpha-MSH) for inhibiting the binding of meta-[131I]iodobenzoyl -[Nle4,D-Phe7]- alpha-MSH ([Nle4,D-Phe7, Lys11-(131I)MIB]- alpha-MSH) to B16-F1 murine melanoma cells were 89 +/- 9 pM and 112 +/- 22 pM, respectively, suggesting that addition of 4-fluorobenzoate did not compromise alpha-MSH receptor binding affinity. Binding of [Nle4,D-Phe7,Lys11-(18F)PFB]- alpha-MSH was influenced by the specific activity of the preparation (400-1000 Ci/mmol). The normal tissue clearance of [Nle4, D-Phe7, Lys11-(18F) PFB]- alpha-MSH in mice was quite rapid, with little evidence for defluorination.
|
Authors | G Vaidyanathan, M R Zalutsky |
Journal | Nuclear medicine and biology
(Nucl Med Biol)
Vol. 24
Issue 2
Pg. 171-8
(Feb 1997)
ISSN: 0969-8051 [Print] United States |
PMID | 9089709
(Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Fluorine Radioisotopes
- Iodine Radioisotopes
- MSH, alpha, 4-fluorobenzoyl-Nle(4)-Phe(7)-
- Receptors, Pituitary Hormone
- alpha-MSH
- MSH, 4-Nle-7-Phe-alpha-
- MSH receptor
- Melanocyte-Stimulating Hormones
|
Topics |
- Animals
- Binding, Competitive
- Fluorine Radioisotopes
(pharmacokinetics)
- Iodine Radioisotopes
(pharmacokinetics)
- Kinetics
- Melanocyte-Stimulating Hormones
(chemical synthesis, pharmacokinetics)
- Melanoma, Experimental
(metabolism)
- Metabolic Clearance Rate
- Mice
- Mice, Inbred BALB C
- Receptors, Pituitary Hormone
(metabolism)
- Tissue Distribution
- alpha-MSH
(analogs & derivatives, pharmacokinetics)
|